PORCINE XENOGRAFT OR MICROBIAL CELLULOSE IN THE TREATMENT OF PARTIAL THICKNESS BURNS

May 29, 2020 updated by: Folke Sjoberg, University Hospital, Linkoeping

PORCINE XENOGRAFT OR MICROBIAL CELLULOSE IN THE TREATMENT OF PARTIAL THICKNESS BURNS - A RANDOMISED CLINICAL TRIAL

The purpose of this study was to compare two wound dressing products for partial thickness burns in adults.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

After being informed about the study, all patients that had given written informed consent underwent screening. If eligible study participants were randomized to be treated wih either the standard dressing of care; pigskin or a microbial cellulose. Dressing were applied within 72 hours after burn injury. Evaluation was done in an open manner due to the specific characteristics of the dressings. Study particpants were followed weekly until complete wound closure and after that evaluated at 6 and 12 months after injruy for burn scar outcome.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Linköping, Sweden, 58185
        • The Burn Centre at Linköping University Hospital,

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Study participants admitted within 72 hours of injury
  • partial-thickness burns requiring a temporary skin cover
  • written informed consent

Exclusion Criteria:

  • severe coexisting cutaneous trauma
  • chronic or current skin disease,
  • severe cognitive dysfunction or psychiatric disorder
  • pregnant or breast feeding women were excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Porcine xenograft
porcine xenograft derived from dermal porcine skin. Standard of care treatement for partila thickness burn at the specfic centre
EXPERIMENTAL: Microbial cellulose
Novel dressing consisting of a biopolymer spun by the bacteria Acetobacter xylinum (later removed).
polymer dressing synthesized in abundance with Acetobacter Xylinum

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to complete healing of the burn
Time Frame: Evaluated at each visit (1-3 times per week) from admission until complete healing, up to 6 months
Healing time was calculated from the date of injury to the date when the wound bed was assessed as completely (100 %) re-epithelialized, with no need for further dressing changes other than protection against shearing according to the treating physician.
Evaluated at each visit (1-3 times per week) from admission until complete healing, up to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Burn wound infection
Time Frame: Evaluated at each visit (1-3 times per week) from admission until complete healing, up to 6 months

Wound infections were diagnosed (by the burn surgeon) if they fulfilled at least two of the following criteria:

(based on the American Burn Association definition of burn wound infection)

  • Clinical signs such as localised pain and swelling, spreading erythema, and heat at the affected site.
  • Positive bacterial culture growth of the surface wound swab.
  • Signs of systemic infection indicated by a rise in CRP concentration (reference range < 10 mg/L for capillary sampling) together with increased body temperature where other sources of infection have been excluded.
Evaluated at each visit (1-3 times per week) from admission until complete healing, up to 6 months
Burn wound pain
Time Frame: Evaluated at each visit (1-3 times per week) from admission until complete healing, up to 6 months
The patients were asked to estimate the burn wound pain at rest, during activity, and during dressing changes using a numerical rating scale (NRS) where 0 indicated no pain and 10 the worst pain ever imaginable.
Evaluated at each visit (1-3 times per week) from admission until complete healing, up to 6 months
Duration of hospital stay (LOS)
Time Frame: From admission until discharge, up to 6 months
All patients hospitalized for their burns were monitored by the study nurse and the day of discharge was noted in the CRF. Any readmission after initial discharge was also noted and included in the total length of stay.
From admission until discharge, up to 6 months
Burn scar outcome
Time Frame: Evaluated at six and 12 months after injury
Burn scar outcome was evaluated using the Patient Observer Scar Assessment Scale (POSAS). The scale includes two separate subscales, The Observer Sscale, used by an experienced burn occupational therapist and the Patient Sscale, used by the study participants.
Evaluated at six and 12 months after injury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 1, 2016

Primary Completion (ACTUAL)

November 1, 2018

Study Completion (ACTUAL)

November 1, 2019

Study Registration Dates

First Submitted

May 29, 2020

First Submitted That Met QC Criteria

May 29, 2020

First Posted (ACTUAL)

June 2, 2020

Study Record Updates

Last Update Posted (ACTUAL)

June 2, 2020

Last Update Submitted That Met QC Criteria

May 29, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MC-2015

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burn Scar

Clinical Trials on microbial cellulose

Subscribe